 |
Data and Minor Companies to be published 1st qtr. 2013
Rest of written report to be published 2nd qtr. 2013
Base Year: 2012 |
 |
 |
 |
 |
 |
|
|
| |
-
Description
-
Regional Coverage: United States
Download Brochure
Download Fact Sheet
DESCRIPTION
A comprehensive analysis of the U.S. nonprescription drugs industry,
focusing on key trends, developments, challenges, business opportunities,
and new product activity, and offers insights and information on
the following:
- Industry trends
- Market size and performance
- Brand sales and share
- Company sales and share
- New product activity
- Retail distribution
- Regulatory developments
- Rx-to-OTC switch forecasts
- Five-year historical sales
- Five-year sales forecasts
Features user-friendly database that is fully searchable and
exportable that contains sales data, growth, share, and forecasts for
hundreds of brands and companies across 36 categories.
-
Contents
-
| TABLE OF CONTENTS |
 |
|
|
|
|
Introduction
Executive Summary
An executive briefing covering developments in 2012, the impact
of key trends and issues in the nonprescription drug business,
and their future implications for industry participants.
Industry Analysis
A summary of industry developments in 2012 and a five-year
forecast.
The market 2012
Companies
Selling and distribution
Private-label activity
Outlook to 2017
Kline's FutureView forecasting scenarios
The Products
Pertinent information plus insightful analysis of approximately
36 major categories, including category trends and developments;
manufacturers' sales for 2011 and 2012, sales and market
shares for leading brands, new product activity, sales by
retail channel, private-label sales, promotional activity, and outlook
to 2017. The product categories that are covered are
shown in Table 1 below.
Major Companies
Profiles for 15 major companies, including company activities;
sales by product category and major brands in 2011 and 2012;
recent developments including acquisitions, divestitures, and
new products; corporate overview; and an outlook to 2017. The
major companies that will be covered are shown in Table 2 below.
Minor Companies
Brief profiles of approximately 50 smaller marketers of nonprescription
drugs, including corporate sales and profits; nonprescription
drug sales, recent developments, including acquisitions,
divestures, and new product activity, product portfolios,
and traceable media expenditures for 2012.
Advertising
Traceable media expenditures with analysis by product
category and by major company.
|
|
|
|
Table
1: Product Categories Profiled
|
|
Allergy, Asthma, and Sinus Products
|
Internal Analgesics
|
|
|
• Allergy relief products
• Asthma medications
• Sinus medications
|
• Arthritis pain relievers
• General pain relievers
• Menstrual relief products
|
|
|
Cough and Cold Preparations
|
Nutritional Products
|
|
|
• Cold medications
• Cough drops and lozenges
• Cough syrups
• Nasal decongestants
• Sore throat remedies
• Topical vapor products
|
• Herbal products
• Vitamins and minerals
|
|
|
Topical Products
|
|
|
• Anti-itch products
• Corn, callus, and wart removers
• Diaper rash products
• Eye care products
• First aid products
• Fungicidal preparations
• Hair regrowth treatments
• Hemorrhoidal preparations
• Oral care products
• Topical analgesics
|
|
|
Digestive Products
|
|
|
• Antacids and antigas products
• Antidiarrheal preparations
• Antinausea preparations
• Laxatives
|
|
|
Feminine Products
|
|
|
• Contraceptive products
• Feminine deodorants and itching remedies
• Feminine yeast infection remedies
• Personal lubricants
|
|
|
Other Products
|
|
|
• Home diagnostic test kits
• Sleeping aids
• Smoking cessation aids
• Weight loss medications
|
|
|
Table 1: Major Companies Profiled |
- Abbott Laboratories
|
- Perrigo
|
- Bayer
|
- Pfizer
|
- Boehringer-Ingelheim
|
- Prestige Brands
|
- GlaxoSmithKline
|
- Procter & Gamble
|
- Insight Pharmaceuticals
|
- Reckitt Benckiser
|
- Johnson & Johnson
|
- Roche
|
- Merck
|
- Sanofi
|
- Novartis
|
|
-
Scope
-
Nonprescription Drugs USA is an extensive industry resource used widely by marketing executives and other
industry participants for competitive analysis, market investigation for new products, acquisition screening, and
business planning.
For more than 40 years, the study has proven to be the most authoritative and comprehensive annual source of
information on the nonprescription drug industry. It contains industry trends and market size data for 36 product
categories. In addition, market share and brand sales information are reported. The study profiles 14
leading major companies. Included in the report is an analysis of regulatory developments, retail distribution, and
private-label activity.
-
Key Benefits
-
Subscribers to Nonprescription Drugs USA are afforded the following benefits:
- Access to the most comprehensive and authoritative independent source of information and insights on the U.S.
nonprescription drugs industry
- Access to accurate sales data through all outlets based on primary research with knowledgeable industry
participants
- Invitation to participate in Kline's annual web conference with access to Kline's analysts and an in-depth presentation
about market performance and industry trends
- A tool to learn about categories or brands that could be potential new entry/acquisition opportunities
- Access to periodic podcasts on timely topics from Kline's industry experts
- A source of valuable competitive information and intelligence
- Understand industry trends that may impact your categories and/or brands
- Learn about expected future Rx-to-OTC switches and their expected impacts on existing OTC categories
- Depth of knowledge with historical sales and trend information, as well as five-year sales forecasts
- Assessment of new product activity in each category
- Access to Kline’s searchable, exportable database with sales data on hundreds of brands and companies across36 categories
- Now includes findings from consumer research on key market trends
- Subscribers to this study are entitled to a discount on Kline's new Nonprescription Drugs USA Active Ingredients database
-
Methodology
-
Kline is unmatched in our ability to gather hard-to-get market and competitive intelligence with a high degree of
accuracy. Kline's market analysis approach places the principal emphasis on primary research techniques to ensure
that the foundation of business intelligence and insight is accurate, current, and reliable.
During the course of field research, Kline's professional staff of industry experts will conduct hundreds of in-depth
discussions and personal interviews with a wide range of knowledgeable industry participants and opinion leaders,
including nonprescription drug manufacturers, retailers, suppliers, and industry associations. This approach has
proven to be the most effective and reliable approach to obtaining accurate market data, capturing expert insights,
and identifying business opportunities. The report also includes findings from online consumer research conducted by Kline with over 300 consumers about their perceptions, usage, and purchase habits of OTC drugs.
Primary research comprises the bulk of the overall research methodology for this report. In addition, this
analysis is supplemented by dedicated, full-time rigorous searches of secondary research drawn from the
review of company materials such as financial filings and press releases, regular searches of trade and technical
literature; Internet sources; store checks; and analysis of statistical data from government, industry, and trade
associations and agencies.
|
|
|
 |
|